These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 830773)

  • 61. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
    Mandle R; Kaplan AP
    J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunoelectrophoretic studies of prekallikrein in human plasma.
    Hathaway WE; Christian J; McGregor R; Borden C
    Thromb Res; 1982 Feb; 25(3):267-75. PubMed ID: 6917563
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Isolation and characterization of bovine plasma prekallikrein (Fletcher factor).
    Heimark RL; Davie EW
    Biochemistry; 1979 Dec; 18(25):5743-50. PubMed ID: 518867
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
    Shimada T; Kato H; Maeda H; Iwanaga S
    J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor.
    Webster ME; Guimaraes JA; Kaplan AP; Colman RW; Pierce JV
    Adv Exp Med Biol; 1976; 70(00):285-99. PubMed ID: 937135
    [No Abstract]   [Full Text] [Related]  

  • 67. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein.
    Sealey JE; Atlas SA; Laragh JH; Silverberg M; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5914-8. PubMed ID: 42905
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW; Edelman R; Scott CF; Gilman RH
    J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Contact activation of prekallikrein and plasminogen in plasma].
    Veremeenko KN; Volokhonskaia LI; Kizim AI; Pogorelaia NF
    Ukr Biokhim Zh (1978); 1983; 55(3):295-301. PubMed ID: 6553425
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High and low molecular weight kininogen and plasma prekallikrein/plasma kallikrein in villous capillaries of human term placenta.
    Hermann A; Buchinger P; Somlev B; Rehbock J
    Placenta; 1996 May; 17(4):223-30. PubMed ID: 8761966
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Defective esterase and kinin-forming activity in human Fletcher trait plasma. A fraction rich in kallikreinlike activity.
    Donaldson VH; Saito H; Ratnoff OD
    Circ Res; 1974 May; 34(5):652-62. PubMed ID: 4545268
    [No Abstract]   [Full Text] [Related]  

  • 72. Activation mechanism of human Hageman factor-plasma kallikrein-kinin system by Vibrio vulnificus metalloprotease.
    Miyoshi S; Shinoda S
    FEBS Lett; 1992 Aug; 308(3):315-9. PubMed ID: 1380471
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human plasma prekallikrein and high molecular weight kininogen decrease during parturition.
    Alving BM; Niebyl JR; Proud D; Mason BL; Pisano JJ
    Thromb Res; 1984 Jun; 34(6):473-7. PubMed ID: 6564799
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Flaujeac trait. Deficiency of human plasma kininogen.
    Wuepper KD; Miller DR; Lacombe MJ
    J Clin Invest; 1975 Dec; 56(6):1663-72. PubMed ID: 127805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dextran-induced anaphylactoid reaction in man: altered reactivity of high molecular weight kininogen.
    Briseid G; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):119-26. PubMed ID: 6159774
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A different cleavage site for high molecular weight kininogen in vivo following intravenous injection of dextran sulfate in the rabbit.
    Wiggins RC
    Circ Res; 1986 Apr; 58(4):595-604. PubMed ID: 2421941
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein.
    Shimada T; Kato H; Iwanaga S
    J Biochem; 1987 Oct; 102(4):913-21. PubMed ID: 3436959
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material.
    Egberg N; Gallimore MJ
    Adv Exp Med Biol; 1983; 156 (Pt B)():1109-17. PubMed ID: 6552857
    [No Abstract]   [Full Text] [Related]  

  • 80. Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction.
    Alving BM; Hojima Y; Pisano JJ; Mason BL; Buckingham RE; Mozen MM; Finlayson JS
    N Engl J Med; 1978 Jul; 299(2):66-70. PubMed ID: 661863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.